News – Page 1059 – Endpoints News

SIGN UP

Biogen, UCB step up to kick the tires at Acorda as buyout buzz grows — report

8 years ago

The next Emflaza: Acer Therapeutics looks to take a page out of Marathon's book

8 years ago

Carmot closes $15M round to advance diabetes drug; Argos board clears reverse stock split, moves to small cap market

8 years ago

Beefing up its CAR-T pipeline, Gilead teams up with Pfizer on a lymphoma combo

8 years ago

Insider trading scam spurred by $11.2B Gilead deal earns a stretch in prison

8 years ago

Novartis ties a new round of biosimilar development programs to a partnership deal with India's Biocon

8 years ago

Tired of being gouged for old, cheap therapies, a consortium of hospitals is going into the drug business — NYT

8 years ago

With $58M in hand, the startup team at Pandion sets their sights on a next-gen approach to immunology

8 years ago

Where the money is: Top 100 VCs investing in US biotechs during 2017

8 years ago

With Pfizer in hot pursuit, J&J loses a critical patent fight as it scrambles for a new prostate cancer drug OK

8 years ago

France's Owkin raises $11M Series A for AI-aided drug development; AstraZeneca expands discovery deal with X-Chem

8 years ago

FDA and Pentagon forge breakthrough designation agreement

8 years ago

Merck KGaA taps UK cancer research organizations to feed pipeline

8 years ago

After a bruising year, Aeterna Zentaris inks a $24M upfront US pact for growth hormone asset

8 years ago

Kymriah gets speedy reviews in US and EU as Novartis looks to swiftly expand CAR-T indications

8 years ago

Is Juno worth a $10B-$12B buyout price? Analysts see megabucks deal in the making on reported Celgene talks

8 years ago

FDA commissioner Scott Gottlieb just broke a public promise on publishing CRLs — and yes, it matters

8 years ago

AveXis wants $400M more for promising SMA gene therapy; ShangPharma partners with Icahn School of Medicine at Mount ...

8 years ago

China biotech unicorn Innovent in talks on $200M IPO and new funding — report

8 years ago

Developers are laying the foundation for a new biotech complex in California

8 years ago

German drugmaker files $21.6M IPO for skin cancer drug

8 years ago

Eiger Bio scraps a mid-stage program after researchers record a clear flop in PAH, shares skid lower

8 years ago

Merck’s Keytruda combo wows again, acing PhIII overall survival goal for lung cancer early

8 years ago

Preclinical study finds Genmab may hold the key to a next-gen triple followup to MEK/BRAF combos

8 years ago

First page Previous page 1056 1057 105810591060 1061 1062 Next page Last page